Douglas Reed M.D., 10% Owner at G1 Therapeutics, Inc. (GTHX), bought 232,846 shares at $15.00 ($2.0M) on 2017-05-22, disclosed to the SEC on 2017-05-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 99,513 | $0 | 0.0% |
| 2 | $15.00 | 133,333 | $2.0M | 100.0% |
| Total | $8.59 avg | 232,846 | $2.0M | 100% |
| Filing → |
| CLSD | SELL | 2017-01-19 | $512K | — | Filing → |
| TLOG | BUY | 2013-12-19 | $1000K | — | Filing → |
| DRAD | SELL | 2007-08-27 | $92K | — | Filing → |